List of Levitra drug patents

Levitra is owned by Bayer Hlthcare.

Levitra contains Vardenafil Hydrochloride.

Levitra has a total of 2 drug patents out of which 0 drug patents have expired.

Levitra was authorised for market use on 19 August, 2003.

Levitra is available in tablet;oral dosage forms.

Levitra can be used as treatement of erectiile dysfunction by administering a film-coated tablet.

The generics of Levitra are possible to be released after 23 July, 2027.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8841446 BAYER HLTHCARE Medicaments containing vardenafil hydrochloride trihydrate
Jul, 2023

(5 months from now)

US8273876 BAYER HLTHCARE Medicaments containing vardenafil hydrochloride trihydrate
Jul, 2027

(4 years from now)

Drugs and Companies using VARDENAFIL HYDROCHLORIDE ingredient

Market Authorisation Date: 19 August, 2003

Treatment: Treatement of erectiile dysfunction by administering a film-coated tablet

Dosage: TABLET;ORAL

How can I launch a generic of LEVITRA before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in